Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 47 (3), 187-192
- https://doi.org/10.1016/0304-3835(89)90089-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Suppression of rat mammary cancer development by N-(4-hydroxy-phenyDretinamide (4-HPR) following surgical removal of first palpable tumorCarcinogenesis: Integrative Cancer Research, 1989
- Therapeutic effect of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinomaEuropean Journal of Cancer and Clinical Oncology, 1988
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986
- N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE PHARMACOKINETICS IN FEMALE RATS AND MICE1986
- Retinoid-tamoxifen interaction in mammary cancer chemopreventionCarcinogenesis: Integrative Cancer Research, 1986
- GROWTH-INHIBITION BY RETINOL OF A HUMAN-BREAST CARCINOMA CELL-LINE INVITRO AND IN ATHYMIC MICE1984
- Phase II trial of 13-cis-retinoic acid in metastatic breast cancerEuropean Journal of Cancer and Clinical Oncology, 1982
- ENHANCED INHIBITION OF MAMMARY CARCINOGENESIS BY COMBINED TREATMENT WITH N-(4-HYDROXYPHENYL)RETINAMIDE AND OVARIECTOMY1982
- N-(4-HYDROXYPHENYL)RETINAMIDE - NEW RETINOID FOR PREVENTION OF BREAST-CANCER IN THE RAT1979
- Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosoureaNature, 1977